SEC Form 4 · accession 0001179110-16-022552
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dorothy E Puhy
Director
Period of report
Mar 31, 2016
Accepted (ET)
Apr 1, 2016 · 5:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par valueF4,F5 | Mar 31, 2016 | S | 4,398 | $95.0145 | D | 47,792 | D | |
| Common Stock, $0.01 par valueF4,F6 | Apr 1, 2016 | S | 5,602 | $95.0232 | D | 42,190 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1,F3 | $12.69 | holding | — | — | — | Aug 13, 2008 | Aug 8, 2017 | Common Stock | 0 | 8,000 | D |
| Stock Option (right to buy)F2,F3 | $18.63 | holding | — | — | — | Aug 12, 2009 | Aug 13, 2018 | Common Stock | 0 | 13,500 | D |
| Stock Option (right to buy)F2,F3 | $7.67 | holding | — | — | — | Aug 11, 2010 | Aug 12, 2019 | Common Stock | 0 | 13,500 | D |
| Stock Option (right to buy)F2,F3 | $9.99 | holding | — | — | — | Aug 10, 2011 | Aug 11, 2020 | Common Stock | 0 | 13,500 | D |
Explanation of responses
- F1Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan.
- F2Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- F3This option becomes exerciseable in full on the date set forth in Table II, Column 6.
- F4Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- F5This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $95.0000 and $95.0900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F6This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $95.0000 and $95.0500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.